SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Deparle Nancy Ann – ‘4’ for 7/25/07 re: Triad Hospitals Inc.

On:  Wednesday, 7/25/07, at 12:34pm ET   ·   For:  7/25/07   ·   As:  Director   ·   Accession #:  1229802-7-25   ·   File #:  1-14695

Previous ‘4’:  ‘4’ on 7/3/07 for 6/30/07   ·   Next:  ‘4’ on 10/2/07 for 9/30/07   ·   Latest:  ‘4’ on 11/17/23 for 11/15/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/25/07  Deparle Nancy Ann                 4          Director    1:11K  Triad Hospitals Inc.              Dombroski Kimberly J/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML     11K 
                Securities by an Insider -- edgar.xml/2.2                        




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
EDGAR System rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Expires:January 31, 2005
Estimated average burden hours per response...0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
DEPARLE NANCY ANN
  2. Issuer Name and Ticker or Trading Symbol
TRIAD HOSPITALS INC [TRI]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
5800 TENNYSON PARKWAY
3. Date of Earliest Transaction (Month/Day/Year)
07/25/2007
(Street)

PLANO, TX 75024
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock07/25/2007   D   6,466D $54 0 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $24.9807/25/2007   D     20,000   (1)05/29/2011Common Stock20,000 $29.02 0 D  
Stock Option (right to buy) $40.8407/25/2007   D     7,500   (2)05/21/2012Common Stock7,500 $13.16 0 D  
Stock Option (right to buy) $24.4507/25/2007   D     7,500   (3)05/20/2013Common Stock7,500 $29.55 0 D  
Stock Option (right to buy) $34.1907/25/2007   D     8,000   (4)05/25/2014Common Stock8,000 $19.81 0 D  

Reporting Owners

Reporting Owner Name / AddressRelationships
 Director 10% Owner Officer Other
DEPARLE NANCY ANN
5800 TENNYSON PARKWAY
PLANO, TX 75024
  X      

Signatures

 Rebecca Hurley, as attorney-in-fact for Nancy-Ann DeParle  07/25/2007
**Signature of Reporting PersonDate

Explanation of Responses:

*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)This option, which provided for vesting in four equal annual installments beginning May 29, 2002, was canceled pursuant to the merger agreement between the Issuer, Community Health Systems, Inc. and FWCT-1 Corporation in exchange for a cash payment of $580,400, representing the difference between the exercise price of the option and the cash merger consideration ($54 per share).
(2)This option, which provided for vesting in four equal annual installments beginning May 21, 2003, was canceled in the merger in exchange for a cash payment of $98,700, representing the difference between the exercise price of the option and the cash merger consideration ($54 per share).
(3)This option, which provided for vesting in four equal annual installments beginning May 20, 2004, was canceled in the merger in exchange for a cash payment of $221,625, representing the difference between the exercise price of the option and the cash merger consideration ($54 per share).
(4)This option, which provided for vesting in four equal annual installments beginning May 25, 2005, was canceled in the merger in exchange for a cash payment of $158,480, representing the difference between the exercise price of the option and the cash merger consideration ($54 per share).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Top
Filing Submission 0001229802-07-000025   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 11:02:51.2am ET